Germany, July 15 -- Evonik REXIM has entered into an agreement with Brenntag Specialties Pharma for the exclusive distribution of its REXIM(R) GMP-grade amino acids across most of Europe. Under the agreement, Brenntag will assume responsibility for market development and distribution in key regions including the DACH region, the UK, France, Benelux, Scandinavia, Central and Eastern Europe, Israel and Turkey. Italy, Ukraine, the Middle East and Africa are excluded from the agreement. Evonik REXIM is a leading supplier of high-quality amino acids, with key production capabilities and supply sources located in Europe. The company combines market leadership in fermentation, bioconversion and synthetic-based manufacturing. Its collaboration with...